| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunologic Memory | 6 | 2022 | 374 | 1.840 |
Why?
|
| Autophagy | 8 | 2022 | 927 | 1.630 |
Why?
|
| Dendritic Cells | 8 | 2021 | 1085 | 1.620 |
Why?
|
| Autoimmunity | 4 | 2021 | 263 | 1.560 |
Why?
|
| Mitochondrial Proteins | 4 | 2022 | 369 | 0.990 |
Why?
|
| Apoptosis | 14 | 2022 | 7591 | 0.970 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2020 | 1586 | 0.920 |
Why?
|
| B-Lymphocytes | 6 | 2020 | 1294 | 0.770 |
Why?
|
| HIV-1 | 2 | 2022 | 653 | 0.720 |
Why?
|
| Lymphocyte Activation | 9 | 2020 | 1688 | 0.710 |
Why?
|
| Self Tolerance | 2 | 2011 | 18 | 0.700 |
Why?
|
| Membrane Proteins | 5 | 2022 | 2819 | 0.690 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 223 | 0.680 |
Why?
|
| Viruses | 1 | 2020 | 159 | 0.660 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 189 | 0.630 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2012 | 621 | 0.560 |
Why?
|
| Virus Diseases | 1 | 2020 | 398 | 0.560 |
Why?
|
| Immunization | 2 | 2015 | 397 | 0.550 |
Why?
|
| Caspases | 4 | 2008 | 661 | 0.490 |
Why?
|
| Energy Metabolism | 1 | 2020 | 992 | 0.480 |
Why?
|
| bcl-X Protein | 3 | 2012 | 196 | 0.480 |
Why?
|
| Mitochondria | 6 | 2022 | 1282 | 0.460 |
Why?
|
| Caspase 9 | 4 | 2020 | 189 | 0.460 |
Why?
|
| Cytological Techniques | 1 | 2013 | 74 | 0.430 |
Why?
|
| HIV Infections | 2 | 2022 | 2134 | 0.420 |
Why?
|
| T-Lymphocytes | 9 | 2021 | 3869 | 0.410 |
Why?
|
| Perforin | 1 | 2011 | 52 | 0.410 |
Why?
|
| Erythropoiesis | 2 | 2008 | 74 | 0.410 |
Why?
|
| Animals | 34 | 2022 | 59536 | 0.400 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2003 | 1756 | 0.390 |
Why?
|
| Mice | 22 | 2022 | 34495 | 0.390 |
Why?
|
| Adoptive Transfer | 5 | 2022 | 446 | 0.390 |
Why?
|
| fas Receptor | 1 | 2011 | 185 | 0.380 |
Why?
|
| Mice, Knockout | 9 | 2022 | 5710 | 0.370 |
Why?
|
| Reticulocytes | 3 | 2008 | 55 | 0.360 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2011 | 675 | 0.350 |
Why?
|
| Hepatitis B virus | 6 | 1997 | 217 | 0.340 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 284 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 1493 | 0.310 |
Why?
|
| Interferon-gamma | 1 | 2011 | 1144 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 673 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 6942 | 0.290 |
Why?
|
| Influenza, Human | 1 | 2014 | 925 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2012 | 2488 | 0.280 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2003 | 107 | 0.280 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2022 | 275 | 0.260 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 1033 | 0.250 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2021 | 23 | 0.230 |
Why?
|
| Autoantibodies | 2 | 2021 | 576 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2015 | 3033 | 0.210 |
Why?
|
| Transcription Factor AP-1 | 2 | 2022 | 246 | 0.210 |
Why?
|
| Tuberculosis Vaccines | 1 | 2021 | 12 | 0.210 |
Why?
|
| Virus Latency | 1 | 2022 | 78 | 0.200 |
Why?
|
| Hepatitis B Core Antigens | 3 | 1996 | 27 | 0.200 |
Why?
|
| Terpenes | 1 | 2021 | 34 | 0.200 |
Why?
|
| Inflammation | 1 | 2011 | 2522 | 0.200 |
Why?
|
| Cell Survival | 5 | 2015 | 3045 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 6 | 2003 | 3101 | 0.190 |
Why?
|
| Mucous Membrane | 1 | 2021 | 271 | 0.190 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 1995 | 187 | 0.180 |
Why?
|
| Virus Activation | 1 | 2022 | 228 | 0.180 |
Why?
|
| Cell Separation | 2 | 2013 | 612 | 0.180 |
Why?
|
| Autoantigens | 1 | 2021 | 234 | 0.180 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 355 | 0.180 |
Why?
|
| Macaca mulatta | 1 | 2022 | 717 | 0.180 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2011 | 72 | 0.180 |
Why?
|
| Germinal Center | 1 | 2020 | 161 | 0.180 |
Why?
|
| Interleukin-2 | 4 | 2003 | 842 | 0.170 |
Why?
|
| Signal Transduction | 11 | 2008 | 11965 | 0.170 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 354 | 0.170 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2011 | 367 | 0.170 |
Why?
|
| Janus Kinase 3 | 8 | 2003 | 46 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 1021 | 0.160 |
Why?
|
| Cytochromes c | 2 | 2008 | 118 | 0.160 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1997 | 11 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 376 | 0.150 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 314 | 0.150 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2017 | 72 | 0.150 |
Why?
|
| Spleen | 2 | 2013 | 676 | 0.150 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 97 | 0.150 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 426 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 166 | 0.150 |
Why?
|
| Multigene Family | 2 | 2012 | 425 | 0.140 |
Why?
|
| Influenza A virus | 1 | 2017 | 270 | 0.140 |
Why?
|
| Adenoviridae | 1 | 2021 | 1459 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 3230 | 0.130 |
Why?
|
| NF-kappa B | 2 | 2022 | 1549 | 0.130 |
Why?
|
| Haptens | 1 | 2015 | 15 | 0.130 |
Why?
|
| Hemocyanins | 1 | 2015 | 50 | 0.130 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2015 | 33 | 0.130 |
Why?
|
| Cytokines | 5 | 2021 | 2809 | 0.130 |
Why?
|
| Dimerization | 2 | 2007 | 304 | 0.130 |
Why?
|
| Acute Disease | 1 | 2020 | 2422 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2003 | 467 | 0.130 |
Why?
|
| Transcription Factors | 5 | 2015 | 5270 | 0.120 |
Why?
|
| DNA-Binding Proteins | 7 | 2003 | 4821 | 0.120 |
Why?
|
| Enzyme Activation | 4 | 2007 | 1764 | 0.120 |
Why?
|
| COS Cells | 5 | 2003 | 377 | 0.120 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 139 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 1399 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2015 | 5637 | 0.110 |
Why?
|
| Point Mutation | 4 | 2000 | 769 | 0.110 |
Why?
|
| Jurkat Cells | 3 | 2008 | 311 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 7548 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 534 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 242 | 0.100 |
Why?
|
| Lung | 2 | 2017 | 3151 | 0.100 |
Why?
|
| Transfection | 7 | 2002 | 2944 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1320 | 0.100 |
Why?
|
| HeLa Cells | 6 | 2003 | 1643 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 4143 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2017 | 677 | 0.100 |
Why?
|
| Biological Assay | 1 | 2012 | 177 | 0.100 |
Why?
|
| Milk Proteins | 2 | 2003 | 116 | 0.090 |
Why?
|
| Models, Immunological | 1 | 2010 | 77 | 0.090 |
Why?
|
| Humans | 28 | 2021 | 261506 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 3639 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 6295 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 582 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 149 | 0.090 |
Why?
|
| Genes, Dominant | 2 | 2007 | 331 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 943 | 0.080 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 53 | 0.080 |
Why?
|
| Protein Binding | 4 | 2007 | 3438 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 635 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 133 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 7222 | 0.080 |
Why?
|
| Erythroid Cells | 1 | 2008 | 49 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2012 | 1146 | 0.080 |
Why?
|
| Liver | 2 | 1994 | 2961 | 0.080 |
Why?
|
| Base Sequence | 8 | 2003 | 4917 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 2003 | 6089 | 0.080 |
Why?
|
| Cell Communication | 1 | 2010 | 509 | 0.080 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2007 | 65 | 0.070 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 2927 | 0.070 |
Why?
|
| Peptides | 1 | 2013 | 1479 | 0.070 |
Why?
|
| Gene Expression | 1 | 2015 | 3570 | 0.070 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 46 | 0.070 |
Why?
|
| Caspase Inhibitors | 1 | 2006 | 95 | 0.070 |
Why?
|
| Trans-Activators | 4 | 2003 | 1555 | 0.070 |
Why?
|
| RNA, Viral | 2 | 2020 | 671 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 1487 | 0.070 |
Why?
|
| Binding Sites | 6 | 2000 | 2171 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 394 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 3343 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2006 | 435 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 93 | 0.060 |
Why?
|
| Enzyme Stability | 1 | 2002 | 105 | 0.050 |
Why?
|
| Models, Biological | 2 | 2012 | 3254 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 145 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 87 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2022 | 39 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 184 | 0.050 |
Why?
|
| RNA Interference | 2 | 2022 | 1408 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 1265 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 38 | 0.050 |
Why?
|
| Cathepsins | 1 | 2021 | 46 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 471 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 5395 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2000 | 1152 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 2314 | 0.050 |
Why?
|
| Galectins | 1 | 2021 | 71 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2000 | 1213 | 0.050 |
Why?
|
| Mutation | 2 | 2001 | 15179 | 0.050 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2002 | 1732 | 0.050 |
Why?
|
| Longevity | 1 | 2022 | 154 | 0.050 |
Why?
|
| Organophosphates | 1 | 2020 | 41 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 253 | 0.050 |
Why?
|
| Female | 6 | 2021 | 141928 | 0.050 |
Why?
|
| Viral Core Proteins | 1 | 1999 | 22 | 0.050 |
Why?
|
| Male | 5 | 2021 | 123000 | 0.050 |
Why?
|
| Cattle | 1 | 2021 | 783 | 0.040 |
Why?
|
| Azepines | 1 | 2020 | 124 | 0.040 |
Why?
|
| Forecasting | 1 | 2002 | 694 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2003 | 611 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 448 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 347 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2000 | 303 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 593 | 0.040 |
Why?
|
| Growth | 1 | 1999 | 117 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 206 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2021 | 399 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 314 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2003 | 1152 | 0.040 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2017 | 13 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 644 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 261 | 0.040 |
Why?
|
| DNA Replication | 1 | 2021 | 744 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 1582 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 4233 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 1997 | 355 | 0.040 |
Why?
|
| Hepatitis B e Antigens | 1 | 1996 | 10 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 2146 | 0.040 |
Why?
|
| Cigarette Smoking | 1 | 2017 | 88 | 0.040 |
Why?
|
| Homeostasis | 1 | 2022 | 950 | 0.040 |
Why?
|
| Piperazines | 2 | 2020 | 2101 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 639 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 220 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2021 | 1694 | 0.030 |
Why?
|
| Triazoles | 1 | 2020 | 617 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 250 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 2216 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 419 | 0.030 |
Why?
|
| Cell Line | 4 | 2012 | 5114 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1996 | 182 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 1994 | 6 | 0.030 |
Why?
|
| Genes, p53 | 1 | 1999 | 1090 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 1123 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 1994 | 40 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1995 | 84 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1994 | 65 | 0.030 |
Why?
|
| Genes, Viral | 1 | 1994 | 202 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2001 | 1555 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1998 | 874 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 1439 | 0.030 |
Why?
|
| Pyridines | 1 | 2020 | 1244 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1995 | 694 | 0.030 |
Why?
|
| Virus Replication | 1 | 1996 | 709 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 79 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 1859 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2012 | 227 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 208 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1996 | 3154 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 671 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 2 | 2003 | 214 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 8 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2003 | 4804 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2008 | 92 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 3552 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 194 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 301 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2003 | 6550 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2000 | 1070 | 0.020 |
Why?
|
| Restriction Mapping | 2 | 1995 | 264 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 51 | 0.010 |
Why?
|
| Base Composition | 1 | 2003 | 92 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 164 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2003 | 96 | 0.010 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 1879 | 0.010 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2001 | 47 | 0.010 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2001 | 44 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 699 | 0.010 |
Why?
|
| Staurosporine | 1 | 2001 | 143 | 0.010 |
Why?
|
| Catalysis | 1 | 2001 | 250 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 111 | 0.010 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 60 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 118 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2000 | 124 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 844 | 0.010 |
Why?
|
| Growth Substances | 1 | 2000 | 300 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 571 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 549 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2008 | 1823 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1999 | 186 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2000 | 408 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2001 | 478 | 0.010 |
Why?
|
| Genes, myc | 1 | 2000 | 358 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 1442 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 121 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 176 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 904 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 528 | 0.010 |
Why?
|
| Cyclins | 1 | 1999 | 456 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 301 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1999 | 278 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1999 | 515 | 0.010 |
Why?
|
| Regulatory Factor X1 | 1 | 1997 | 8 | 0.010 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 1997 | 24 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1997 | 67 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 875 | 0.010 |
Why?
|
| Metallothionein | 1 | 1996 | 34 | 0.010 |
Why?
|
| Hepacivirus | 1 | 1999 | 397 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 87 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1996 | 73 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 354 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 869 | 0.010 |
Why?
|
| Tyrosine | 1 | 1997 | 498 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2000 | 679 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1996 | 226 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 957 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1999 | 2027 | 0.010 |
Why?
|
| Methylation | 1 | 1996 | 597 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 682 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 161 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1996 | 258 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 483 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 1993 | 29 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 6150 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 889 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 3203 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 1399 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 1062 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 14551 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 2693 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 4053 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1993 | 246 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1999 | 4557 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 1618 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2001 | 3518 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2000 | 5159 | 0.000 |
Why?
|
| Infant | 1 | 2003 | 13310 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1993 | 1620 | 0.000 |
Why?
|
| United States | 1 | 2003 | 15433 | 0.000 |
Why?
|
| Neoplasms | 2 | 1999 | 15193 | 0.000 |
Why?
|